Status:
UNKNOWN
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Collaborating Sponsors:
RainMed Medical Group
Conditions:
Microvascular Coronary Artery Disease
STEMI
Eligibility:
All Genders
18-80 years
Brief Summary
Despite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately a half of patients with ST-segment elevation myocardial infarction (...
Detailed Description
Despite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately a half of patients with ST-segment elevation myocardial infarction (...
Eligibility Criteria
Inclusion
- Aged between 18 and 80, regardless of gender;
- Initially diagnosed as STEMI and underwent primary PCI;
- Voluntarily participated in this trial and signed the informed consent form.
Exclusion
- Coronary angiography shows that PCI is not suitable;
- Past history of coronary artery bypass grafting (CABG);
- Past history of heart failure;
- Past history of myocardial infarction;
- Primary or secondary cardiomyopathy or heart valve disease;
- Patients with renal insufficiency (eGFR\<30ml/min (1.73m\^2)) or patients undergoing dialysis;
- Cardiogenic shock
- Persistent left or right coronary ostium lesion after target vessel PCI;
- Immediate effect of target vessel PCI is unsatisfactory \[such as thrombolysis in myocardial infarction (TIMI) flow \< grade 2, dissection that restricted blood flow, side branch occlusion (diameter\>1.5mm), exist distal embolism or angiographically visible thrombus\];
- Target vessel exist coronary fistula or myocardial bridge (lumen constriction \>50%);
- The target vessel cannot clearly expose the lesion in two positions with an included angle ≥ 30 degrees;
- Severe systemic infection
- Patients with malignant wasting disease, with an estimated survival of less than 1 year;
- The subject is participating in another clinical researches, and the primary endpoint has not been reached;
- The investigator believes that the subject has other conditions that are not suitable for clinical trials.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT06118450
Start Date
November 1 2023
End Date
May 31 2025
Last Update
November 8 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Luhe Hospital.Capital Medical University
Beijing, Beijing Municipality, China
2
Peking University First Hospital
Beijing, Beijing Municipality, China
3
Huai'an First People's Hospital
Huai'an, Jiangsu, China
4
The First People'S Hospital of Lianyungang
Lianyungang, Jiangsu, China